바이오메디컬 텍스타일 시장 : 섬유 관리자, 직물 유형 및 용도별 - 세계 예측(2025-2030년)

The Biomedical Textile Market was valued at USD 12.61 billion in 2023, expected to reach USD 13.54 billion in 2024, and is projected to grow at a CAGR of 7.48%, to USD 20.91 billion by 2030.

Biomedical textiles are specialized fabrics engineered for medical purposes that interact with biological systems, encompassing a wide scope from wound dressings to implantable devices. These textiles are crucial in healthcare for their biocompatibility, sterilizability, and functional versatility, addressing applications from surgical sutures to prosthetic skins. The necessity for innovative biomedical textiles is propelled by the increasing incidence of chronic diseases, aging populations, and heightened surgical interventions, fostering advancements in materials such as antimicrobial finishes and bioactive textiles. End-use applications span hospitals, clinics, and homecare, with a growing emphasis on personalized medicine solutions. Key growth factors shaping the market include technological advancements, increased R&D investment, and rising healthcare expenditure globally. Additionally, the COVID-19 pandemic has accelerated innovations aimed at infection prevention, expanding potential opportunities for antimicrobial and antiviral textiles. Nevertheless, challenges persist, such as stringent regulatory compliances, high production costs, and material limitations that may hinder market growth. For businesses aiming to capitalize on emerging opportunities, focusing on innovations such as smart textiles that monitor health parameters or organic, biodegradable fibers can offer competitive edges. The intersection of textiles with IoT presents unexplored avenues for innovation, with significant room for growth in wearable health monitoring devices. Adaptation to the stringent international standards governing bio-textiles and investment in sustainable production technologies will likely influence market expansion favorably. While the market is competitive, strategic partnerships and collaborations can advance development efforts, helping navigate challenges like high entry barriers for new entrants. Overall, the biomedical textile market presents robust growth potential driven by urgent clinical needs and technological synergy, with opportunities for differentiation in smart and sustainable product lines.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomedical Textile Market

The Biomedical Textile Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of accidents and surgeries
  • Rapid growth in the aging population, and increased healthcare expenditure
  • Demand for TAVR incorporated textiles to prevent abrasion and encourage tissue growth
• Market Restraints
  • Complex raw material and heavy investments
• Market Opportunities
  • Advancements in surgical robotics resulting for close collaboration between textile developers and medical device OEMs
  • Advancements in smart biomedical textiles
• Market Challenges
  • Lack of trained skilled manpower with interdisciplinary knowledge

Porter's Five Forces: A Strategic Tool for Navigating the Biomedical Textile Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomedical Textile Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomedical Textile Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomedical Textile Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomedical Textile Market

A detailed market share analysis in the Biomedical Textile Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomedical Textile Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomedical Textile Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomedical Textile Market

A strategic analysis of the Biomedical Textile Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomedical Textile Market, highlighting leading vendors and their innovative profiles. These include ARAN BIOMEDICAL, Asahi Kasei Corporation, ATEX Technologies, Inc., B. Braun Melsungen AG, Bally Ribbon Mills, BSN Medical by Svenska Cellulosa Aktiebolaget SCA, Cardinal Health, Inc, Confluent Medical Technologies, CORTLAND BIOMEDICAL by Tufropes Pvt Ltd., Integra LifeSciences Corporation, J-Pac, LLC, Johnson & Johnson Services Inc., Koninklijke DSM N.V., Medline Industries, LP, Medtronic PLC, Meister & Cie AG, PAUL HARTMANN AG, Poly-Med Incorporated, Schouw & Co AS, Secant Group LLC, Shieldex by Statex Production and Sales GmbH, SurgicalMesh, Swicofil AG, The Freudenberg Group, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Biomedical Textile Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Fiber Manager, market is studied across Biodegradable Fiber and Non-Biodegradable Fiber. The Biodegradable Fiber is further studied across Chitin and Collagen. The Non-Biodegradable Fiber is further studied across Cotton, Polyamide, Polyester, Polypropylene & Polyethylene, Polytetrafluoroethylene, Polyurethane, and Viscose.
• Based on Fabric Type, market is studied across Hollow Fabric, Knitted & Braided Fabric, Non-Woven Fabric, and Woven Fabric.
• Based on Application, market is studied across Extracorporeal Devices, Implantable, Non-Implantable, and Surgical Sutures. The Implantable is further studied across Dental Prosthesis, Hard Tissue Implants, Soft Tissue Implants, and Vascular Devices.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of accidents and surgeries
    • 5.1.1.2. Rapid growth in the aging population, and increased healthcare expenditure
    • 5.1.1.3. Demand for TAVR incorporated textiles to prevent abrasion and encourage tissue growth
  • 5.1.2. Restraints
    • 5.1.2.1. Complex raw material and heavy investments
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in surgical robotics resulting for close collaboration between textile developers and medical device OEMs
    • 5.1.3.2. Advancements in smart biomedical textiles
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of trained skilled manpower with interdisciplinary knowledge
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biomedical Textile Market, by Fiber Manager

• 6.1. Introduction
• 6.2. Biodegradable Fiber
  • 6.2.1. Chitin
  • 6.2.2. Collagen
• 6.3. Non-Biodegradable Fiber
  • 6.3.1. Cotton
  • 6.3.2. Polyamide
  • 6.3.3. Polyester
  • 6.3.4. Polypropylene & Polyethylene
  • 6.3.5. Polytetrafluoroethylene
  • 6.3.6. Polyurethane
  • 6.3.7. Viscose

7. Biomedical Textile Market, by Fabric Type

• 7.1. Introduction
• 7.2. Hollow Fabric
• 7.3. Knitted & Braided Fabric
• 7.4. Non-Woven Fabric
• 7.5. Woven Fabric

8. Biomedical Textile Market, by Application

• 8.1. Introduction
• 8.2. Extracorporeal Devices
• 8.3. Implantable
  • 8.3.1. Dental Prosthesis
  • 8.3.2. Hard Tissue Implants
  • 8.3.3. Soft Tissue Implants
  • 8.3.4. Vascular Devices
• 8.4. Non-Implantable
• 8.5. Surgical Sutures

9. Americas Biomedical Textile Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Biomedical Textile Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Biomedical Textile Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ARAN BIOMEDICAL
• 2. Asahi Kasei Corporation
• 3. ATEX Technologies, Inc.
• 4. B. Braun Melsungen AG
• 5. Bally Ribbon Mills
• 6. BSN Medical by Svenska Cellulosa Aktiebolaget SCA
• 7. Cardinal Health, Inc
• 8. Confluent Medical Technologies
• 9. CORTLAND BIOMEDICAL by Tufropes Pvt Ltd.
• 10. Integra LifeSciences Corporation
• 11. J-Pac, LLC
• 12. Johnson & Johnson Services Inc.
• 13. Koninklijke DSM N.V.
• 14. Medline Industries, LP
• 15. Medtronic PLC
• 16. Meister & Cie AG
• 17. PAUL HARTMANN AG
• 18. Poly-Med Incorporated
• 19. Schouw & Co AS
• 20. Secant Group LLC
• 21. Shieldex by Statex Production and Sales GmbH
• 22. SurgicalMesh
• 23. Swicofil AG
• 24. The Freudenberg Group
• 25. W. L. Gore & Associates, Inc.